Effects of nimodipine on tissue lactate and malondialdehyde levels in experimental head trauma

Anaesthesia and Intensive Care

Volumn 29, Issue 5, 2001, Pages 484-488

  Ak, A ^a   Ustun M E ^a   Ogun C O ^a   Duman, A ^a   Bor, M A ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Head trauma: lactate; Lipid peroxidation; Malondialdehyde; Nimodipine

Indexed keywords

KETAMINE; LACTIC ACID; MALONALDEHYDE; NIMODIPINE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEAD INJURY; MALE; NONHUMAN; RABBIT; TIME; TISSUE LEVEL; TISSUE SECTION;

EID: 0034791462     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0102900506     Document Type: Article

References (37)

1. The metabolic response to severe head injury
2. Calcium in physiological and pathological cell function
3. Calcium antagonists: History and perspective
4. Accumulation of calcium in the brain following head trauma
5. DNA damage and oxygen radical toxicity
6. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites
7. Oxygen-derived free radical damage in organ preservation: Activity of superoxide dismutase and xanthine oxidase
8. The measurement and mechanism of lipid peroxidation in biological systems
9. The molecular basis of brain injury and brain edema. The role of oxygen free radicals
10. Hyperglycemia, cerebrospinal fluid lactic acidosis and cerebral blood flow in severely head injured patients
11. CSF brain creatine kinase levels and lactic acidosis in severe head injury
12. Effect of hyperglycemia on brain cell membrane function and energy metabolism during hypoxic ischemia in newborn piglets
13. Cerebral function and preservation during cardiac arrest
14. Possible role of calcium entry blockers in brain protection
15. Pharmacology of nimodipine. A review
16. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease
17. Diverse mechanisms of neuronal protection by nimodipine in experimental rabbit brain ischemia
18. Prevention of cerebrovascular spasm with nimodipine
19. Efficacy of prophylactic nimodipine for delayed ischaemic deficit after subarachnoid haemorrhage: A meta-analysis
20. The effect of NMDA, AMPA/kinase and calcium channel antagonists on traumatic cortical neuronal injury in culture
21. Effect of a combination of pentoxifylline and nimodipine on lipid peroxidation in postischemic rat brain
22. Cystosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage
23. Use of polyethylene glycol-bound superoxide dismutase, polyethylene glycol-bound catalase, and nimodipine to prevent hypoxic ischemic injury to the brain of newborn pigs
24. Effect of nimodipine and N- acetyl cysteine on lipid peroxidation after experimental spinal cord injury
25. The effects of nimodipine on outcome after head injury: A prospective randomized control trial. The British/Finnish Co-operative Head Injury Trial Group
26. Nimodipine does not affect cerebral lactate levels following complete ischemia in dogs
27. Responses to cortical injury. I. Methodology and local effects of contusions in the rat
28. Effect of naloxone on sodium- and potassium- activated and magnesium-dependent adenosine-5′-triphosphatase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury
29. Cerebral neuroprotection and ketamine
30. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury
31. Lipid peroxidation in experimental spinal cord injury: Time-level relationship
32. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging
33. Cerebral blood flow, cerebral blood volume and cerebrovascular reactivity after severe head injury
34. Concussive brain injury is associated with a prolonged accumulation of calcium: A 45Ca autoradiographic study
35. Calcium in the brain under physiological and pathological conditions
36. Pharmacology of calcium antagonists: Clinical relevance in neurology
37. Effect of hyperglycemia on pyruvate dehydrogenase activity and energy metabolites during ischemia and reperfusion in gerbil brain